Cafepharma Today

September 19 2024 - Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Roche reports positive data from Phase III influenza treatment trial
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
CNBC
Thursday, September 19, 2024 - 11:13am
tags:
Novartis, Pharma CEOs, weight loss, obesity, Vas Narasimhan
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Medical Marketing and Media
Thursday, September 19, 2024 - 11:08am
tags:
Havas Lynx, pharma marketing, climate change
4DMT’S Gene Therapy for AMD Clears Phase II, Heads to Late-Stage Studies
BioSpace
Thursday, September 19, 2024 - 11:07am
tags:
4DMT, gene therapy, AMD, clinical trials, wet age-related macular degeneration
Navigating the AI 'hype cycle': Bayer, Daiichi Sankyo and argenx leaders on implementing AI in biopharma marketing
Fierce Pharma
Thursday, September 19, 2024 - 11:06am
tags:
artificial intelligence, Bayer, Daiichi Sankyo, Argenx
Starton successfully delivers cancer drug using on-body injector
Clinical Trials Arena
Thursday, September 19, 2024 - 11:05am
tags:
Starton Therapeutics, lenalidomide, cancer, drug delivery, on-body injector
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
Fierce Biotech
Thursday, September 19, 2024 - 9:29am
tags:
Vanda Pharmaceuticals, FDA, gastroparesis, clinical trials, tradipitant
Cercle secures $6M seed fundraise to advance women’s healthcare
Businesswire
Thursday, September 19, 2024 - 9:27am
tags:
Cercle, funding, artificial intelligence, Women's Health
Roche reports positive data from Phase III influenza treatment trial
Clinical Trials Arena
Thursday, September 19, 2024 - 9:24am
tags:
Roche, Flu, clinical trials, Xofluza
FDA inspection backlog overseas threatens new drug approvals
Pharma Voice
Thursday, September 19, 2024 - 9:23am
tags:
FDA, regulatory inspections, regulatory, drug approvals
At J&J, oncology R&D meets commercial strategy in a quest for new standards of care
Pharma Voice
Thursday, September 19, 2024 - 9:22am
tags:
JNJ, R&D, oncology
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
Pharmaphorum
Thursday, September 19, 2024 - 9:21am
tags:
GSK, COPD, ICER, drug pricing, Medicare
FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
BioSpace
Wednesday, September 18, 2024 - 11:16pm
tags:
Merck, Keytruda, mesothelioma, FDA
Fresenius Kabi Ivenix Pump Sees Second Recall in 2024
Medical Devices and Diagnostics Industry
Wednesday, September 18, 2024 - 11:13pm
tags:
Medtech, Fresenius Kabi, device recalls, Ivenix Infusion Pump LVP
Respiratory disorder biotech Upstream Bio files for a $100 million IPO
Renaissance Capital
Wednesday, September 18, 2024 - 11:10pm
tags:
Upstream Bio, monoclonal antibodies, IPOs, Respiratory
Masimo's Fate To Be Decided Thursday
Medical Devices and Diagnostics Industry
Wednesday, September 18, 2024 - 11:08pm
tags:
Masimo, Medtech, Politan Capital
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
Reuters
Wednesday, September 18, 2024 - 11:05pm
tags:
GAVI, Bavarian Nordic, mpox, vaccines
FDA Approves Fasenra for Treatment of Eosinophilic Granulomatosis with Polyangiitis
Managed Healthcare Executive
Wednesday, September 18, 2024 - 11:03pm
tags:
AstraZeneca, Fasenra, eosinophilic granulomatosis with polyangiitis
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
Fierce Biotech
Wednesday, September 18, 2024 - 1:56pm
tags:
Applied Therapeutics, govorestat, FDA, Rare Diseases
Ascendis trial data piles pressure on BioMarin
BioPharma Dive
Wednesday, September 18, 2024 - 1:42pm
tags:
Ascendis Pharma, Biomarin, Voxzogo, achondroplasia
Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama
Fierce Pharma
Wednesday, September 18, 2024 - 1:39pm
tags:
Organon, Roivant, Dermavant, M&A, immuno-dermatology

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information